ADPT is trading 4.15% up at $22.34 as it extends a sharp multi-day rally driven by growing investor confidence in its clonoSEQ platform and broader pipeline.
- The stock has climbed significantly from $17.23 on June 23 to its current price, marking a period of sustained upward momentum.
- No new company-specific announcements were identified for July 1, suggesting the move is a continuation of recent gains rather than a response to a fresh catalyst.